Share statistics (as at 2 January 2018)

Number of Ordinary Shares in issue (undiluted) 120,696,002
Number of Ordinary Shares subject to options 6,507,500
Maximum number of Ordinary Shares in issue (fully diluted) 127,203,502

The effect of the options, if all were exercised, would be to increase the issued share capital by 5.39% and raise £3,145,813 for the Company.

There are no restrictions on the transfer of Futura Medical plc shares.

Major shareholders (as at 2 January 2018)

Shareholders holding more than 3% of the share capital of Futura were:

Lombard Odier Asset Management (Europe) Limited 18.9%
Octopus Asset Management 7.9%
RA Lamb 7.9%
WT Lamb Investments Limited 3.9%
Medinvest Holdings Limited 3.5%

Shares not in public hands (as at 2 January 2018)

In terms of the AIM Rules and insofar as it is aware, 20.63% of the Company's AIM securities are not in public hands.

Shares held in treasury (as at 2 January 2018)

In terms of the AIM Rules, there are no shares held in treasury.

Share volumes (as at 2 January 2018)

The daily average number of shares traded since 2012 is:

Daily Average Per Year Since 2012 ('000)   Daily Average Per Month in 2017 ('000)
2016 295   Jan 386 Jun 176 Nov 345
2015 155   Feb 269 Jul 127 Dec 326
2014 154   Mar 347 Aug 275    
2013 225   Apr 175 Sep 399    
2012 180   May 224 Oct 660    

Share options (as at 2 January 2018)

The number of ordinary shares subject to options granted under the Share Option Schemes of the Company were:

Grant Exercise period (incl) Exercise price/share No of share options granted Cash to Company on exercise
9/11 10/13 - 9/18 56.50p 627,500 £354,538
9/12 10/14 - 9/19 61.50p 660,000 £405,900
9/13 10/15 - 9/20 71.50p 750,000 £536,250
9/14 10/16 - 9/21 51.75p 710,000 £367,425
9/15 10/17 - 9/22 30.00p 1,060,000 £318,000
1/17 10/18 - 9/23 57.50p 1,260,000 £724,500
9/17 10/19 - 9/24 30.50p 1,440,000 £439,200
Totals     6,507,500 £3,145,813

Further details of share options issued can be obtained from the Company's Annual Report 2016 which can be found in the Annual and Interim Reports section.

 

Page last updated: 9 January 2018